During the last 20 years, IT systems and software such as those used in regulatory, clinical, safety, and document management have been implemented across life sciences organizations. Whether utilized as a best-of-breed approach, a single-platform strategy, or a mix of both, the goal was the same: increase the accuracy, efficiency, and usability of information by shifting from paper-based processes to electronic ones.
While inconsistent in some areas, overall these results have been impressive. Higher-quality data flows more easily and quickly between organizations and to the people who need it – increasing efficiency and productivity while improving patient safety and trial outcomes. What’s more, these software-augmented processes have also helped reduce organizational risk in clinical development and regulatory compliance.
It has become clear that the benefits provided by the adoption of software and systems in the life sciences industry have reached a plateau.
Fortunately, when an industry reaches a plateau – like the one life sciences has reached today – there are always companies that have seen it coming and began developing solutions to solve the challenge. For a time, these transformational technologies exist in parallel with existing systems, and are often picked up by forward-thinking early adopters.
In this executive brief, we draw on our extensive experience helping leading pharmaceutical companies worldwide gain significant time and cost savings by implementing Robotic Process Automation designed specifically for life sciences.